Supportive care in neurooncology

Revue Neurologique

Volumn 167, Issue 10, 2011, Pages 762-772

  Taillandier, L ^a   Blonski, M ^a   Darlix, A ^a   Hoang Xuan, K ^b   Taillibert, S ^b   Cartalat Carel, S ^c   Piollet, I ^d   Le Rhun, E ^e,f,g  

^a UNIVERSITY HOSPITAL OF NANCY   (France)

^b SORBONNE UNIVERSITÉ   (France)

^c HÔPITAL NEUROLOGIQUE   (France)

^d INSTITUT SAINTE CATHERINE   (France)

^e CENTRE OSCAR LAMBRET   (France)

^f CENTRE HOSPITALIER DE VALENCIENNES   (France)

^g LILLE UNIVERSITY HOSPITAL   (France)

Author keywords

Brain tumors; Quality of life; Supportive care

Indexed keywords

ANALGESIC AGENT; ANTICOAGULANT AGENT; BENZODIAZEPINE DERIVATIVE; BETAMETHASONE; BEVACIZUMAB; CORTICOSTEROID; CORTISONE; DALTEPARIN; DEXAMETHASONE; ETIRACETAM; ETOPOSIDE; HALOPERIDOL; HARKOSERIDE; HYDROCORTISONE; LAMOTRIGINE; LOW MOLECULAR WEIGHT HEPARIN; METHYLPHENIDATE; METHYLPREDNISOLONE; NEUROLEPTIC AGENT; NITROSOUREA; OLANZAPINE; OXCARBAZEPINE; PREDNISOLONE; PREDNISONE; PREGABALIN; RISPERIDONE; TOPIRAMATE; TRIAMCINOLONE; UNINDEXED DRUG; VALPROIC ACID;

ALERTNESS; BEHAVIOR DISORDER; BLEEDING; BRAIN EDEMA; BRAIN METASTASIS; BRAIN TUMOR; CANCER SURVIVAL; CAUSE OF DEATH; CLINICAL FEATURE; COLIC PERFORATION; CONFERENCE PAPER; CONFUSION; DEEP VEIN THROMBOSIS; DELIRIUM TREMENS; DIABETES MELLITUS; DIGESTIVE SYSTEM PERFORATION; DRUG ACTIVITY; DRUG HALF LIFE; DRUG MEGADOSE; DYSPHAGIA; EPILEPSY; ETHICS; EXTRAPYRAMIDAL SYMPTOM; EYE DISEASE; FECES INCONTINENCE; GASTRODUODENAL ULCER; GLIOBLASTOMA; GLIOMA; HEADACHE; HEMIPARESIS; HUMAN; INTERMITTENT PNEUMATIC COMPRESSION DEVICE; INTRACRANIAL HYPERTENSION; INTRACRANIAL PRESSURE; INTRATUMORAL BLEEDING; LUNG EMBOLISM; MENTAL DISEASE; MUSCLE DISEASE; MUSCLE TOXICITY; MYOPATHY; NEUROLOGIC DISEASE; NONHUMAN; PAIN; PERIOPERATIVE PERIOD; PNEUMOCYSTOSIS; PRESCRIPTION; RISK FACTOR; SENILE OSTEOPOROSIS; SKIN DISEASE; THROMBOCYTOPENIA; URINE INCONTINENCE; VENOUS THROMBOEMBOLISM;

ANTICOAGULANTS; BRAIN NEOPLASMS; CONFUSION; EPILEPSY; HUMANS; INTRACRANIAL HYPERTENSION; MEDICAL ONCOLOGY; PALLIATIVE CARE; QUALITY OF LIFE; TERMINAL CARE; VENOUS THROMBOSIS;

EID: 81955160740     PISSN: 00353787     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neurol.2011.08.008     Document Type: Conference Paper

References (138)

1. G. Agnelli, and M. Verso Thromboprophylaxis during chemotherapy after advanced cancer Thromb Res 120 Suppl 2 2007 S128 S132 (Pubitemid 350101781)
2. D. Aguiar, R. Pazo, I. Duran, J. Terressa, A. Arrivi, and H. Manzano Toxic epidermal necrolysis in patients receiving anticonvulsivants and cranial irradiation: a risk to consider J Neurooncol 66 2004 345 350 (Pubitemid 38258350)
3. A. Alcalay, T. Wun, V. Khatri, H.K. Chew, D. Harvey, and H. Zhou Venous thromboembolism in patients with colorectal cancer: incidence and effect on survival J Clin Oncol 24 2006 1112 1118 (Pubitemid 46638808)
4. Y. Alici-Evcimen, and W. Breitbart An update on the use of anti-psychotics in the treatment of delirium Palliat Support Care 6 2008 177 182
5. M. Angelo, C. Ruchalski, and B.J. Sproge An approach to diabetes mellitus in hospice and palliative medicine J Palliat Med 14 2011 83 87
6. C. Ay, R. Vormittag, D. Dunkler, R. Simanek, A.L. Chiriac, and J. Drach D-dimer and prothrombin fragment 1 + 2 predict venous thromboembolism in patients with cancer: results from the Vienna Cancer and Thrombosis Study J Clin Oncol 27 2009 4124 4129
7. T.T. Batchelor, and T.N. Byrne Supportive care of brain tumor patients Hematol Oncol Clin North Am 20 2006 1337 1361 (Pubitemid 44755418)
8. T.T. Batchelor, L.P. Taylor, H.T. Thaler, J.B. Posner, and L.M. DeAngelis Steroid myopathy in cancer patients Neurology 48 1997 1234 1238 (Pubitemid 27240540)
9. R.A. Blaheta, M. Michaelis, P.H. Driever, and J. Cinatl Jr. Evolving anticancer drug valproic acid: insights into the mechanism and clinical studies Med Res Rev 25 2005 383 397 (Pubitemid 40946533)
10. S. Bond Delirium resolution in hospitalized older patients with cancer Cancer Nurs 31 6 2008 444 450
11. V. Bonito, V. Bonito, A. Caraceni, L. Borghi, N. Marcello, and M. Mori The clinical and ethical appropriateness of sedation in palliative neurologic treatment Neurol Sci 26 2005 370 385 (Pubitemid 43091352)
12. V. Bourg, C. Lebrun, R.M. Chichmanian, P. Thomas, and M. Frenay Nitroso-urea-cisplatin-based chemotherapy associated with valproate: increase of hematologic toxicity Ann Oncol 12 2001 217 219 (Pubitemid 32223871)
13. D. Boyle Delirium in older adults with cancer: implications for practice and research Oncol Nurs Forum 33 1 2006 61 78
14. A.A. Brandes, E. Scelzi, G. Salmistraro, M. Ermani, C. Carollo, and F. Berti Incidence of risk of thromboembolism during treatment high-grade gliomas: a prospective study Eur J Cancer 33 1997 1592 1596 (Pubitemid 28123480)
15. W. Breitbart, E. Bruera, H. Chochinov, and M. Lynch Neuropsychiatric syndromes and psychological symptoms in patients with advanced cancer J Pain Symptom Manage 10 2 1995 131 141
16. W. Breitbart, and Y. Alici Agitation and delirium at the end of life "We could not manage him" JAMA 300 24 2008 2898 2910
17. C. Brogna, S. Gil Robles, and H. Duffau Brain tumors and epilepsy Expert Rev Neurother 8 2008 941 955 (Pubitemid 351872598)
18. S.H. Bush, and E. Bruera The assessment and management of delirium in cancer patients Oncologist 14 2009 1039 1049
19. T.N. Byrne, T.L. Cascino, and J.B. Posner Brain metastasis from melanoma J Neurooncol 1 1983 313 317 (Pubitemid 14163771)
20. L.B. Castillo, G.A. Bugedo, and J.L. Paranhos Mannitol or hypertonic saline for intracranial hypertension? A point of view Crit Care Resusc 11 2009 151 154
21. R. Cavaliere, and D. Schiff Fatal pulmonary embolism despite an inferior vena cava filter in glioblastoma multiforme Neurocrit Care 3 2005 249 250 (Pubitemid 43004820)
22. J.B. Chalk, K. Ridgeway, T. Brophy, J.D. Yelland, and M.J. Eadie Phenytoin impairs the bioavailability of dexamethasone in neurological and neurosurgical patients J Neurol Neurosurg Psychiatry 47 1984 1087 1090 (Pubitemid 14006191)
23. H.K. Chew, T. Wun, D. Harvey, H. Zhou, and R.H. White Incidence of venous thromboembolism and its effect on survival among patients with common cancers Arch Intern Med 166 2006 458 464
24. D. Cinocco The difficulties of swallowing at the end of life J Palliat Med 10 2007 506 508 (Pubitemid 46740225)
25. A.T. Cohen, R. Alikhan, J.I. Arcelus, J.F. Bergmann, S. Haas, and G.J. Merli Assessment of venous thromboembolism risk and the benefits of thromboprophylaxis in medical patients Thromb Haemost 94 2005 750 759 (Pubitemid 41489233)
26. M.L. Daud Drug management of terminal symptoms in advanced cancer patients Curr Opin Support Palliat Care 1 2007 202 206
27. J.F. de Groot, and W.K. Yung Bevacizumab and irinotecan in the treatment of recurrent malignant gliomas Cancer J 14 2008 279 285
28. G.J. de Haan, P. van der Geest, G. Doelman, E. Bertram, and P. Edelbroek A comparison of midazolam nasal spray and diazepam rectal solution for the residential treatment of seizure exacerbations Epilepsia 51 2010 478 482
29. M.E. De Jonge, A.D. Huitema, S.M. van Dam, J.H. Beijnen, and S. Rodenhuis Significant induction of cyclophosphamide and thiotepa metabolism by phenytoin Cancer Chemother Pharmacol 55 2005 507 510 (Pubitemid 40568983)
30. J.Y. Delattre, B. Safai, and J.B. Posner Erythema multiforme and Stvens-Johnson syndrome in patients receiving cranial irradiation and phenytoin Neurology 38 1988 194 198 (Pubitemid 18036835)
31. M.S. Dhami, R.D. Bona, J.A. Calogero, and R.M. Hellman Venous thromboembolism and high grade gliomas Thromb Haemost 70 1993 393 396 (Pubitemid 23254663)
32. S.R. Dietcher Cancer and thrombosis: mechanisms and treatment J Thromb Thrombolysis 16 2003 21 31
33. F. Elice, J. Jacoub, F.R. Rickles, A. Falanga, and F. Rodeghiero Hemostatic complications of angiogenesis inhibitors in cancer patients Am J Hematol 83 2008 862 870
34. D. Elie, P. Gagnon, B. Gagnon, and A. Gigure Using psychostimulants in end-of-life patients with hypoactive delirium and cognitive disorders: a literature review Can J Psychiatry 55 6 2010 386 393
35. N. Fadul, G. Kaur, T. Zhang, J.L. Palmer, and E. Bruera Evaluation of the memorial delirium assessment scale (MDAS) for the screening of delirium by means of simulated cases by palliative care health professionals Support Care Cancer 15 2007 1271 1276 (Pubitemid 47583448)
36. S. Faithfull, K. Cook, and C. Lucas Palliative care of patients with a primary malignant brain tumour: case review of service use and support provided Palliat Med 19 7 2005 545 550 (Pubitemid 41645513)
37. P.A. Forsyth, S. Weaver, D. Fulton, P.M. Brasher, G. Sutherland, and D. Stewart Prophylactic anticonvulsants in patients with brain tumor Can J Neurol Sci 30 2003 106 112 (Pubitemid 36717992)
38. H.S. Friedman, M.D. Prados, P.Y. Wen, T. Mikkelsen, D. Schiff, and L.E. Abrey Bevacizumab alone and in combination with irinotecan in recurrent glioblastoma J Clin Oncol 27 2009 4733 4740
39. B. Gagnon, G. Low, and G. Schreier Methylphenidate hydrochloride improves cognitive function in patients with advanced cancer and hypoactive delirium: a prospective clinical study Rev Psychiatr Neurosci 30 2 2005 100 107
40. P. Gagnon Treatment of delirium in supportive and palliative cancer Curr Opin Support Palliat Care 2 1 2008 60 66
41. C. Galanakis, N.E. Mayo, and B. Gagnon Assessing the role of hydration in delirium at the end of life Curr Opin Support Palliat Care 5 2 2011 169 173
42. J.H. Galicich, and L.A. French Use of dexamethasone in treatment of cerebral oedema resulting from brain tumors and brain surgery Am Pract Dig Treat 12 1961 103 107
43. J.H. Galicich Use of dexamethasone in treatment of cerebral oedema associated with brain tumor J Lancet 31 1961 46 53
44. J.D. Gaudreau, P. Gagnon, and A. Tremblay Psychoactive medication and risk of delirium in hospitalized cancer patients J Clin Oncol 23 27 2005 6712 6718 (Pubitemid 46190266)
45. D.E. Gerber, S.A. Grossman, and M.B. Streiff Management of venous thromboembolism in patients with primary and metastatic brain tumors J Clin Oncol 24 2006 1310 1318 (Pubitemid 46622035)
46. A.J. Ghanim, C. Daskalakis, D.J. Eschelman, and W.K. Kraft A 5-year, retrospective, comparison review of survival in neurosurgical patients diagnosed with venous thromboembolism and treated with either inferior vena cava filters or anticoagulants J Thromb Thrombolysis 24 2007 247 254 (Pubitemid 47617391)
47. P.J. Gilbar, and T.R. Brodribb Phenytoin and fluorouracil interaction Ann Pharmacother 35 2001 1367 1370 (Pubitemid 33042068)
48. M.J. Glantz, B.F. Cole, P.A. Forsyth, L.D. Recht, P.Y. Wen, and M.C. Chamberlain Practice parameter: anticonvulsivant prophylaxis in patients with newly diagnosed brain tumors. Report of the quality standards subcomittee of the American Academy of Neurology Neurology 54 2000 1886 1896
49. S.Z. Goldhaber, K. Dunn, M. Gerhard-Herman, J.K. Park, and P.M. Black Low rate of venous thromboembolism after craniotomy for brain tumor using multimodality prophylaxis Chest 122 2002 1933 1937 (Pubitemid 36051127)
50. M.S. Gordon, and D. Cunningham Managing patients treated with bevacizumab combination therapy Oncology 69 Suppl 3 2005 25 33 (Pubitemid 41680950)
51. R.C. Hartwell, and L.N. Sutton Mannitol, intracranial pressure and vasogenic edema Neurosurgery 32 1993 444 4540
52. A.N. Hays, C. Lazaridis, R. Neyens, J. Nicholas, S. Gay, and J.A. Chalela Osmotherapy: use among neurointensivists Neurocrit Care 14 2011 222 228
53. C. Hemper, E. Weiss, and C.F. Hess Dexamethasone treatment in patients with brain metastasis and primary brain tumors: do the benefits outweigh the side effects? Sup Care Cancer 10 2002 322 328 (Pubitemid 36056287)
54. J. Hidebrand Traité de neurologie: neurooncologie 2001 Doin Edition
55. J. Hidebrand, and M. Brada Differential diagnosis in neurooncology 2001 Oxford University Press
56. J. Hildebrand, C. Lecaille, J. Perennes, and J.Y. Delattre Epileptic seizures during follow-up of patients treated for primary brain tumors Neurology 65 2005 212 215 (Pubitemid 41022363)
57. K. Hoang-Xuan, J.Y. Delattre, and M. Poisson Stevens Johnson syndrome in a patient receiving cranial irradiation and carbamazepine Neurology 40 1990 1144 1145 (Pubitemid 20213994)
58. H. Ikeda, T. Murakami, M. Takano, T. Usui, and K. Kihira Pharmacokinetic interaction on valproic acid and recurrence of epileptic seizures during chemotherapy in an epileptic patient Br J Clin Pharmacol 59 2005 593 597 (Pubitemid 40632251)
59. K.A. Jaeckle, K. Ballman, A. Furth, and J.C. Buckner Correlation of enzyme-inducing anticonvulsant use with outcome of patients with glioblastoma Neurology 73 2009 1207 1213
60. L. Junck Supportive management in neurooncology: opportunities for patient care, teaching and research Curr Opin Neurol 17 2004 649 653 (Pubitemid 39612995)
61. A.K. Kakkar, S. Haas, H. Wolf, and A. Encke Evaluation of perioperative fatal pulmonary embolism and death in cancer surgical patients: the MC-4 cancer substudy Thromb Haemost 94 2005 867 871 (Pubitemid 41489251)
62. R.B. Khan, and A. Onar Seizure recurrence and risk factors after antiepilepsy drug withdrawal in children with brain tumors Epilepsia 47 2006 375 379
63. A.A. Khorana, N.M. Kuderer, E. Culakova, G.H. Lyman, and C.W. Francis Development and validation of a predictive model for chemotherapy-associated thrombosis Blood 111 2008 4902 4907
64. A.A. Khorana, and M.V. Rao Approaches to risk-stratifying cancer patients for venous thromboembolism Thromb Res 120 Suppl 2 2007 S41 S50 (Pubitemid 350103848)
65. M.A. Knovich, and G.J. Lesser The management of thromboembolic disease in patients with central nervous system malignancies Curr Treat Options Oncol 5 2004 511 517 (Pubitemid 39591810)
66. H. Konishi, K. Morita, T. Minouchi, M. Nakajima, M. Matsuda, and A. Yamaji Probable metabolic interaction of doxifluridine with phenytoin Ann Pharmacother 36 2002 831 834 (Pubitemid 34517414)
67. T.N. Kreisl, L. Kim, K. Moore, P. Duic, C. Royce, and I. Stroud II trial of single-agent bevacizumab followed by bevacizumab plus irinotecan at tumor progression in recurrent glioblastoma J Clin Oncol 27 2009 740 745
68. H.G. Krouwer, J.L. Pallagi, and N.M. Graves Management of seizures in brain tumor patients at the end of life J Palliat Med 3 2000 465 475 (Pubitemid 32056759)
69. G. Kyle End of life: a need for bowel care guidance Nurs Times 107 2011 20 22
70. S.E. Langmore, G. Grillone, A. Elackattu, and M. Walsh Disorders of swallowing: palliative care Otolaryngol Clin North Am 42 2009 87 105
71. J.W. Lee, P.Y. Wen, S. Hurwitz, P. Black, S. Kesari, and J. Drappatz Morphological characteristics of brain tumors causing seizures Arch Neurol 67 2010 336
72. M. Leonard, M. Agar, C. Mason, and P. Lawlor Delirium issues in palliative care settings J Psychosom Res 65 2008 289 298
73. J.M. Levin, D. Schiff, J.S. Loeffler, H.A. Fine, P.M. Black, and P.Y. Wen Complications of therapy for venous thromboembolic disease in patients with brain tumors Neurology 43 1993 1111 1114 (Pubitemid 23177708)
74. J. Lin, M.C. Proctor, M. Varma, L.J. Greenfield, G.R. Upchurch Jr. , and P.K. Henke Factors associated with recurrent venous thromboembolism in patients with malignant disease J Vasc Surg 37 2003 976 983 (Pubitemid 36538919)
75. B. Liptzin, and S.E. Levkoff An empirical study of delirium subtypes Br J Psychiatry 161 1992 843 845
76. Lonergan E, Britton AM. Antipsychotics for delirium Cochrane Database System Rev. 2009 (2) CDOO5594.
77. G.H. Lyman, A.A. Khorana, A. Falanga, D. Clarke-Pearson, C. Flowers, and M. Jahanzeb American Society of Clinical Oncology. American Society of Clinical Oncology guideline: recommendations for venous thromboembolism prophylaxis and treatment in patients with cancer J Clin Oncol 25 2007 5490 5505 (Pubitemid 350232226)
78. M. Maschio, L. Dinapoli, A. Zarabia, and B. Jandolo Issues related to the pharmacological management of patients with brain tumours and epilepsy Funct Neurol 21 2006 15 19 (Pubitemid 43985840)
79. S. Mercadante, G. Intravaia, P. Villari, P. Ferrera, F. David, and A. Casuccio Controlled sedation for refractory symptoms in dying patients J Pain Symptom Manage 37 2009 771 779
80. R. Michelucci Optimizing therapy of seizures in neurosurgery Neurology 67 2006 S14 S18 (Pubitemid 44967991)
81. T. Nakasaki, H. Wada, C. Shigemori, C. Miki, E.C. Gabazza, and T. Nobori Expression of tissue factor and vascular endothelial growth factor is associated with angiogenesis in colorectal cancer Am J Hematol 69 2002 247 254 (Pubitemid 34259846)
82. S.R. Nalluri, D. Chu, R. Keresztes, X. Zhu, and S. Wu Risk of venous thromboembolism with the angiogenesis inhibitor bevacizumab in cancer patients: a meta-analysis JAMA 300 2008 2277 2285
83. P.L. Nghiemphu, R.M. Green, W.B. Pope, A. Lai, and T.F. Cloughesy Safety of anticoagulation use and bevacizumab in patients with glioma Neuro Oncol 10 2008 355 360
84. S. Oberndorfer, E. Lindeck-Pozza, H. Lahrmann, W. Struhal, P. Hitzenberger, and W. Grisold The end-of-life hospital setting in patients with glioblastoma J Palliat Med 11 1 2008 26 30
85. S. Oberndorfer, T. Schmal, H. Lahrmann, S. Urbanitis, K. Lindner, and W. Grisold The frequency of seizures in patients with primary brain tumors or cerebral metastasis. An evaluation from the Ludwig Boltzmann Institute of Neurooncology and Department of neurology, Kaiser Franz Josef Hospital Vienna. Klin Wochenschr 114 2002 911 916 (Pubitemid 35453292)
86. F. Oner Dinchas, S. Yoruk, C. Demirkesen, O. Uzel, and S. Koca Toxic epidermal necrolysis after cranial radiotherapy and phenytoin treatment Onkologie 27 2004 389 392 (Pubitemid 39274237)
87. A. Pace, C.D. Lorenzo, L. Guariglia, B. Jandolo, C.M. Carapella, and A. Pompili End of life issues in brain tumor patients J Neurooncol 91 1 2009 39 43
88. A. Pace, G. Metro, and A. Fabi Supportive care in neurooncology Curr Opin Oncol 22 2010 621 626
89. J.A. Paice, and B. Ferrell The management of cancer pain CA Cancer J Clin 61 2011 157 182
90. P.N. Patsalos, and E. Peruca Clinically important drug interactions in epilepsy: interactions between antepileptic drugs ans other drugs Lancet Neurol 2 2003 473 481 (Pubitemid 36876104)
91. J.R. Perry, J.A. Julian, N.J. Laperriere, W. Geerts, G. Agnelli, and L.R. Rogers PRODIGE: a randomized placebo-controlled trial of dalteparin low-molecular-weight heparin thromboprophylaxis in patients with newly diagnosed malignant glioma J Thromb Haemost 8 2010 1959 1965
92. E. Perucca Clinically relevant interactions with antiepileptic drugs Br J Clin Pharmacol 61 2006 246 255 (Pubitemid 43382623)
93. J.B. Posner Neurologic complications of cancer 1995 FA Davis Company Philadelphia
94. J.B. Posner Management of brain metastasis Rev Neurol (Paris) 148 1992 477 487
95. R.A. Purdy, and S. Kirby Headaches and brain tumors Neurol Clin 22 2004 39 53 (Pubitemid 38228437)
96. M. Reich, R. Rohn, and D. Lefevre Surgical intensive care unit (ICU) delirium: a "psychosomatic" problem? Palliat Support Care 8 2010 221 225
97. H.I. Robins, A. O'Neill, M. Gilbert, M. Olsen, R. Sapiente, and B. Berkey Effect of dalteparin and radiation on survival and thromboembolic events in glioblastoma multiforme: a phase II ECOG trial Cancer Chemother Pharmacol 62 2008 227 233 (Pubitemid 351692078)
98. R.A. Rodas, R.A. Fenstermaker, P.E. McKeever, M. Blaivas, L.D. Dickinson, and S.M. Papadopoulos Correlation of intraluminal thrombosis in brain tumor vessels with postoperative thrombotic complications: a preliminary report J Neurosurg 89 1998 200 205 (Pubitemid 28346137)
99. A. Rosati, L. Buttolo, R. Stefini, A. Todeschini, M. Cenzato, and Padovani A Efficacy and safety of levetiracetam in patients with glioma: a clinical prospective study Arch Neurol 67 2010 343
100. F. Rosenow, P.S. Reif, A. Haag, K. Schmidt, H. Strik, and K.A. Jaeckle Correlation of enzyme-inducing anticonvulsant use with outcome of patients with glioblastoma Neurology 74 2010 1330 1331
101. A.O. Rossetti, R. Stupp, K.A. Jaeckle, K. Ballman, A. Furth, and J.C. Buckner Correlation of enzyme-inducing anticonvulsant use with outcome of patients with glioblastoma Neurology 74 2010 1329 1330
102. R. Rud, E. Trevisan, and R. Soffietti Epilepsy and brain tumors Curr Opin Oncol 22 2010 611 620
103. R.L. Ruff, and J.B. Posner Incidence and treatment of peripheral venous thrombosis in patients with glioma Ann Neurol 13 1983 334 336
104. B. Sade, R.A. Prayson, and J.H. Lee Gliosarcoma with infratemporal fossa extension. Case report J Neurosurg 105 2006 904 907 (Pubitemid 44917395)
105. J. Santiago-Palma, and R. Payne Palliative care and rehabilitation Cancer 92 4 Suppl 2001 1049 1052
106. D. Schiff, and P. Wen Cancer neurology in clinical practice 2003 Humana Press Totowa, New Jersey
107. D. Schiff, and L.M. DeAngelis Therapy of venous thromboembolism in patients with brain metastases Cancer 73 1994 493 498 (Pubitemid 24030634)
108. D. Schiff, and P.Y. Wen Cancer neurology in clinical practice 2003 Humana Press Totowa, New Jersy
109. M.A. Schleinich, S. Warren, C. Nekolaichuk, T. Kaasa, and S. Watanabe Palliative care rehabilitation survey: a pilot study of patients' priorities for rehabilitation goals Palliat Med 22 2008 822 830
110. C. Schunn, G.B. Schunn, G. Hobbs, L.C. Vona-Davis, and U. Waheed Inferior vena cava filter placement in late-stage cancer Vasc Endovascular Surg 40 2006 287 294 (Pubitemid 44450491)
111. R.E. Schwarz, A.M. Marrero, K.C. Conlon, and M. Burt Inferior vena cava filters in cancer patients: indications and outcome J Clin Oncol 14 1996 652 657 (Pubitemid 26051033)
112. T.J. Semrad, R. O'Donnell, T. Wun, H. Chew, D. Harvey, and H. Zhou Epidemiology of venous thromboembolism in 9489 patients with malignant glioma J Neurosurg 106 2007 601 608 (Pubitemid 46536455)
113. R. Simanek, R. Vormittag, M. Hassler, K. Roessler, M. Schwarz, and C. Zielinski Venous thromboembolism and survival in patients with high-grade glioma Neuro Oncol 9 2007 89 95 (Pubitemid 46580310)
114. E.M. Sizoo, L. Braam, T.J. Postma, H.R. Pasman, J.J. Heimans, and M. Klein Symptoms and problems in the end-of-life phase of high-grade glioma patients Neuro Oncol 12 2010 1162 1166
115. H.T. Sørensen, L. Mellemkjaer, J.H. Olsen, and J.A. Baron Prognosis of cancers associated with venous thromboembolism N Engl J Med 343 2000 1846 1850 (Pubitemid 32104130)
116. M.R. Sperling, and J. Ko Seizures and brain tumors Semin Oncol 33 2006 333 341 (Pubitemid 43849932)
117. J.A. Spiller, and J.C. Keen Hypoactive delirium: assessing the extent of the problem for inpatients specialist palliative care Palliat Med 20 1 2006 17 23 (Pubitemid 43224657)
118. A.C. Spyropoulos, D.J. Brotman, A.N. Amin, S.B. Deitelzweig, A.K. Jaffer, and S.C. McKean Prevention of venous thromboembolism in the cancer surgery patient Cleve Clin J Med 75 Suppl 3 2008 S17 S26
119. D. Stagno, C. Gibson, and W. Breitbart The delirium subtypes: A review of prevalence, phenomenology, pathophysiology, and treatment response Palliat Support Care 2 2004 171 179
120. G.H. Stevens Antiepileptic therapy in patients with central nervous system malignancies Curr Neurol Neurosci Rep 6 2006 311 318 (Pubitemid 44069970)
121. M.B. Streiff, J. Segal, S.A. Grossman, T.S. Kickler, and E.G. Weir ABO blood group is a potent risk factor for venous thromboembolism in patients with malignant gliomas Cancer 100 2004 1717 1723 (Pubitemid 38456351)
122. L. Taillandier, and H. Duffau Epilepsy and insular Grade II gliomas: an interdisciplinary point of view from a retrospective monocentric series of 46 cases Neurosurg Focus 27 2 2009 E8
123. S. Taillibert, F. Laigle-Donadey, and M. Sanson Palliative care in patients with primary brain tumors Curr Opin Oncol 16 6 2004 587 592 (Pubitemid 39482979)
124. S. Talibert, and J.Y. Delattre Palliative care in patients with brain metastases Curr Opin Oncol 17 2005 588 592
125. M.S. van Breemen, E.B. Wilms, and C.J. Vecht Epilepsy in patients with brain tumours: epidemiology, mechanisms, and management Lancet Neurol 6 2007 421 430 (Pubitemid 46551867)
126. C.J. Vecht, A. Hovestadt, H.B. Verbiest, J.J. van Vleit, and W.L. van Putten Dose effect relationship of dexamethasone on Karnofsky performance in metastatic brain tumors: a randomised study of doses of 4, 8 and 16 mg per day Neurology 44 1994 675 680 (Pubitemid 24129996)
127. C.J. Vecht, and M. van Breemen Optimizing therapy of seizures in patients with brain tumors Neurology 67 suppl 2006 10 13
128. C.J. Vecht, G.L. Wagner, and E.B. Wilms Interactions between antiepileptic and chemotherapeutic drugs Lancet Neurol 2 2003 404 409 (Pubitemid 36793932)
129. V. Venkataramani, C. Rossner, L. Iffland, S. Schweyer, I.Y. Tamboli, and J. Walter Histone deacetylase inhibitor valproic acid inhibits cancer cell proliferation via down-regulation of the alzheimer amyloid precursor protein J Biol Chem 285 2010 10678 10689
130. Vercueil L. Brain tumor epilepsy: a reappraisal and six remaining issues. Rev Neurol, 2011 in press.
131. J.J. Vredenburgh, A. Desjardins, J.E. Herndon, 2nd, J.M. Dowell, D.A. Reardon, and J.A. Quinn Phase II trial of bevacizumab and irinotecan in recurrent malignant glioma Clin Cancer Res 13 2007 1253 1259 (Pubitemid 46424067)
132. D.C. Walsh, and A.K. Kakkar Thromboembolism in brain tumors Curr Opin Pulm Med 7 2001 326 331 (Pubitemid 32929690)
133. P.Y. Wen, D. Schiff, S. Kesari, J. Drappatz, D.C. Gigas, and L. Doherty Medical management of patients with brain tumors J Neurooncol 80 2006 313 332 (Pubitemid 44782910)
134. W. Wick, and W. Küker Brain edema in neurooncology: radiological assessment and management Onkologie 27 2004 261 266 (Pubitemid 39279335)
135. W. Wick, O. Menn, C. Meisner, J. Steinbach, M. Hermisson, and M. Tatagiba Pharmacotherapy of epileptic seizures in glioma patients: who, when, why and how long? Onkologie 28 2005 391 396 (Pubitemid 41558255)
136. K.Y. Yap, W.K. Chui, and A. Chan Drug interactions between chemotherapeutic regimens and antiepileptics Clin Ther 30 2008 1385 1407
137. W.S. Yeow, M.F. Ziauddin, J.B. Maxhimer, S. Shamini-Noori, A. Baras, and A. Chu Potentiation of the anticancer effect of valproic acid, an antiepileptic agent with histone deacetylase inhibitory activity by the kinase inhibitor Stauroporine or its clinically relevant analogue UCN-01 Br J Cancer 94 2006 1436 1445 (Pubitemid 43772278)
138. N.A. Zakai, J. Wright, and M. Cushman Risk factors for venous thrombosis in medical inpatients: validation of a thrombosis risk score J Thromb Haemost 2 2004 2156 2161 (Pubitemid 40185776)